Authors:
Soon-Kyung Hwang, Hwang-Tae Lim, Arash Minai-Tehrani, Eun-Sun Lee, Jongmin Park, Seung Bum Park, George R. Beck, Jr., and Myung-Haing Cho
Summary:
Rationale - Difficulties in achieving long-term survival of patients with lung cancer treated with conventional therapies suggest that novel approaches are required. Recent advances in aerosol-mediated gene delivery have provided the possibility of an alternative for the safe and effective treatment of lung cancer.
Objectives - To investigate the repeated effect of carboxyl-terminal modulator protein (CTMP) on multistage lung tumorigenesis. In this study, we addressed this question by studying the effects of lentivirus-based CTMP in the lungs of 9- and 13-week-old K-rasLA1 mice, a model of lung cancer.
Methods - An aerosol of lentivirus-based CTMP was delivered into 9- and 13-week-old K-rasLA1 mice, a model of lung cancer, through a nose-only inhalation system twice a week for 4 weeks. The effects of CTMP on lung cancer progression and Akt-related signals were evaluated.
Measurements & Main Results - Long-term repeated delivery of CTMP effectively reduced tumor progression in the lungs at different stages of development. Lentiviral-CTMP inhibited protein synthesis and cell cycle and altered Akt signaling pathway in the lungs of 9-week-old K-rasLA1 mice, and increased apoptosis was observed in the lungs of 13-week-old K-rasLA1 mice.
Conclusions - Long-term repeated viral delivery of CTMP may provide a useful tool for designing lung tumor treatment.
Source:
Respiratory & Critical Care Medicine; Vol. 179, 1131-1140 (2009)